It can be difficult to know how some of the aspirations of the guidelines that sound good will actually affect patients care, but the NICE guidelines own expectations in the sections on "How the recommendations might affect practice" seem pretty marginal. More money for ME/CFS specialists?
It's difficult to know how to interpret this.
On them saying the guidelines "raise awareness in the recommendations of the current lack of treatment or cure for ME/CFS" they say: "The recommendations reflect current practice so no impact on resources is anticipated."
Really? When did it become current practice to inform patients that there were no treatments or cures for ME/CFS?
They go on to say in a different section that "The committee reinforced there is no therapy based on physical activity or exercise that is effective as a treatment or cure for ME/CFS."
Am I being stupid or is it really hard to know what is going on here? It's a bit like these guidelines are from a different reality. Whenever I don't know what's going on with ME/CFS it has ended up being much worse that I feared... has this made me paranoid or is this a trap?!
More money for ME specialists;
@Jonathan Edwards has highlighted how rheumatoid arthritis treatment was turned around by specialists. However, as Jonathan has indicated, I wouldn't get your hopes up about getting more resources (e.g. to fund specialists).
I assume (haven't followed this or read guidance) that the conclusion "no impact on resources is anticipated" is based on the "current lack of treatment or cure". Jonathan also highlighted the risk of promoting "current lack of treatment or cure" i.e. you don't get the consultants who were the game changer in rheumatoid arthritis treatment.
Possibly one way to deal with this is to respond to the consultation:
1) agreeing that currently the disease pathology is not understood;
2) highlighting that "clinicians such as Professor Julia Newton, and the biomedical research teams led by Professor Newton (e.g. Cara Tomas), should be funded. This will enable expertise to develop in diagnosis, understanding the underlying disease pathology and ultimately treatment." I assume you're really talking about centres of excellence (EU ERN system).
Don't assume that those who draft policy have sufficient insight - although I'm reassured that Jonathan has inputted. I work at a junior level in (non-health) policy development (devolved Government). A colleague told me of a former colleague, who had made a mess of a public consultation (he'd missed a lot of relevant information) and needed to turn it around - so he arranged for a consultation response to be submitted --- hey presto the new policy emerged! I suggest starting off thinking inept rather than deliberate.
I suggest that you set out your concerns i.e. in a response to the consultation.
What is the last date for submitting responses to the consultation?